Once you have completed the informed consent process, and your doctor registers your participation in the clinical trial, you will then begin the trial process.
If you are taking part in a Phase III trial, you will either receive a new treatment that has already shown promise in treating your condition or the current standard treatment. You may be randomly assigned to one treatment or another. The trial is considered a ‘double-blind study’ if neither you nor your doctor knows which of the treatments you are receiving. All of these options are outlined in your informed consent document.
Throughout your treatment you will be carefully monitored by those involved in running the trial including your clinical care team. If the treatment you receive does not work to treat your condition or if something unexpected happens, such as a severe side effect as a result of the treatment – the treatment will be stopped and your care team will support you with next steps.